inc buy pt ep vs consensu rais estim pt
reiter buy rate analyst michael diana full summari
 buy pt nim pressur posit guidanc lower estim pt
reiter buy growth outlook analyst michael diana full summari
inc buy pt anoth solid quarter regard uk exit posit earn
focu reiter buy price analyst michael diana full summari
inc hold solid quarter stabl credit qualiti still concern
hancock jaff laboratori inc hjli buy pt venovalv posit data keep flow day
corpor event call maxim salesperson inform
horizon technolog financ corp hrzn cover diana ndr boston ceo rob pomeroy cfo
dynatron corpor dynt cover vendetti ndr nyc ceo brian baker vice-president corpor
medicenna corp mdna cover mccarthi ndr nyc ceo fahar merchant phd cfo
california restaur tour habt host mon-tu
cover sullivan ndr philadelphia ceo batrack mon-tu dec
cover sullivan ndr baltimor ceo batrack tue-w dec
graham corpor cover sullivan ndr st loui cfo jeffrey glajch thu dec
graham corpor cover sullivan ndr kansa citi cfo jeffrey glajch fri dec
livexl media inc cover vander aard ndr lo angel ceo rob ellin thu oct
cover chokshi ndr philadelphia ceo jeff rosica fri
nutanix inc cover chokshi ndr san francisco cfo duston mon dec
turtl beach corp hear cover chokshi ndr nyc ceo juergen stark thu dec
pure storag inc cover chokshi ndr nyc execut tbd tue
pure storag inc cover chokshi ndr boston execut tbd wed
ep vs consensu rais
estim pt reiter buy rate
report adjust core ep versu consensu
due wider nim higher fee incom
rais ep estim base
new ep estim rais price target
new price target equat price-to-earnings multipl versu
price-to-earnings multipl previou price target in-line
averag relev small-cap peer
includ non-recur expens versu consensu
beat due wider net interest margin nim higher fee incom mainli loan
sale swap fee loan growth solid exclud loan rockford
 trust agre sell
credit qualiti credit qualiti remain solid view non-performing asset
npa loan net charge-off
averag loan loan loss reserv equal npa
includ purchas account discount acquir loan
rais ep estim mainli due wider nim
page updat earn model expect addit capit
sale rockford bank trust redeploy profit bank
rais price target share current trade
new ep estim new price target equat price-to-earnings
multipl versu price-to-earnings multipl previou price target
in-line averag relev small-cap peer
reiter buy rate next four quarter expect stock price
appreci price target dividend yield
result estim total return
posit acquisit outlook one reason buy rate
past three year complet three success acquisit de
moin iowa cedar rapid iowa springfield missouri typic allow
acquir bank run rel independ perceiv prospect target
favor partner expect make acquisit
click full note
solid quarter stabl credit qualiti still
result beat consensu low due disappoint
result importantli credit qualiti stabl metric revert
normal level manag tighten rais guidanc
still concern
pursuit bank charter
unspecifi timelin creat uncertainti especi regard
implement cost possibl evid broken busi model
maintain hold rate base uncertainti
busi model valuat
result gross revenu slightli guidanc rang
consensu estim adjust net incom
per share high end guidanc rang
consensu estim adjust ebitda
consensu estim manag give
guidanc adjust ebitda
data follow metric except net interest margin adjust
ebitda margin improv compar compar linked-
quarter gross revenu loan net interest margin
vs adjust ebitda margin vs one
factor impact adjust ebitda margin credit qualiti
credit qualiti metric credit qualiti import success factor
view stabl better linked-quart net charge-off averag loan
vs day delinqu
loan vs loan loss reserv
loan vs provis loan
loss origin vs
guidanc base result manag tighten guidanc
gross revenu rais guidanc
adjust net incom per share net incom
per share
rais estim gross revenu adjust
ebitda adjust net income/non-gaap ep
page updat earn model main reason
manag preliminari high-level guidanc lower effect tax
rate previou estim
initi announc nr sign
odx loan origin platform good news enough make
loss organ nr ondx also commenc
maintain hold rate share current trade ev/ebitda multipl
base new estim best compar lc buy
trade ev/ebitda multipl view trade
discount premium expect grow ebitda
faster
click full note
anoth solid quarter regard uk exit posit
earn focu reiter buy price target
result solid within enova guidanc rang though skew
near-cess lend activ uk octob enova
announc exit uk due disput unreason
regard uk exit wise move probabl help earn see
new estim allow manag focu profit
price target repres premium valuat lendingclub
lc buy believ warrant enova consist profit
revenu consensu estim
within guidanc rang adjust ebitda
consensu estim within guidanc rang
ep consensu estim
within guidanc rang
data due materi season enova busi comparison
year-ago quarter typic meaning compar revenu rose
ratio net charge-off averag combin loan vs
gross margin vs adjust ebitda margin
vs accord manag credit qualiti
impact new custom percentag origin come
new custom highest ever sinc compani first year new
custom new custom prior credit histori enova
compani take bigger initi loan loss provis loan loan
repeat custom enova posit credit perform therefor
provis less notwithstand record proport new custom
loan loss provis so-cal cost revenu percentag revenu
less new custom foundat drive posit
long-term result one reason reiter buy rate
revis estim account enova exit uk lower
revenu estim although rais adjust ebitda
estim ep estim
page updat earn model might seem counter-intuit
lower revenu estim rais earn estim
actual experi enova first nine month base select financi
result provid manag enova includ exclud uk oper
expect refin estim see pro forma financi show uk
discontinu oper
maintain price target share current trade ev/
ebitda multipl base new adjust ebitda estim
regard on-line marketplac lender lc buy best compar
growth profil on-line subprime competitor buy best
compar busi model price target enova ev/ebitda
multipl would previous vs elev
credit view premium reason mainli enova
profit sinc wherea might grow faster
yet profit expect
third year profit share current depress due
reiter buy rate enova put togeth good run solid quarterli
result next four quarter expect stock price appreci
price target
click full note
nim pressur posit guidanc lower
estim pt reiter buy growth outlook
result consist consensu reflect strong loan
deposit growth asset-sensit bank nim
relat earn asset growth relat
lower rate net interest incom also
preliminari guidanc posit view stabl net interest incom
versu two addit fed rate cut assum one
addit rate cut lower ep estim base
new estim lower price target
metric except nim strong includ addit
new custom view uniqu best bank
world see therefor abl grow franchis
earn base outperform even interest rate
environ less favor
result summari yesterday post-clos report ep
versu consensu estim linked-quart loan growth
deposit growth stabl credit qualiti core effici
ratio exclud vc invest warrant gain due
regard preliminari guidanc posit tend
much focu net interest margin nim enough net interest incom
view two addit fed rate cut manag guid
nim narrow net interest incom
compar regard posit especi combin
strength fee incom credit qualiti
lower ep estim base growth
earn asset nim loan loss provis averag
loan effici ratio effect tax rate page
updat earn model new ep estim assum total fed rate
cut includ addit cut vs total cut previou estim
regard uniqu non-replic investor day decemb
manag highlight enjoy command market share
among earli stage technolog life scienc compani
power relationship ventur capit vc backer
offer compani includ proprietari advic employe
access network peer industri expert develop
global infrastructur servic relev type compani
grow therebi enabl keep client lifespan
acquisit leerink partner add capit market servic
advisori servic gener signific synergi full-servic
commerci invest bank product offer help attract client
captur greater share client total bank need abl
gener roe even low rate environ fed fund rate
reiter buy rate new price target share current trade
new ep estim new price target equat price-to-earnings multipl
new ep estim versu previou price target
in-line best-in-class smid-cap bank remain top pick among
smid-cap bank long term due uniqu non-replic franchis
growth implic franchis
click full note
venovalv posit data keep flow
hancock jaff present data first-in-pati venovalv
studi congress asian societi vascular surgeri data
includ follow-up patient earlier follow-up
though n-valu small data encourag thu far
day three report measur reflux vcss diseas sever
score va pain score improv importantli patient consid
occlud day appear function valv reflux
reduc baselin baselin day
data bogota studi make compel case venovalv
halt progress fix reflux actual improv diseas
note ulcer heal substanti pain improv symptomat
reduct consid lack effect treatment compress
sock leg elev view studi result could pave
way us pivot trial also begin attract attent larger med-
devic player data well meet fda discuss path forward
follow
venovalv clinic data continu posit studi includ
endpoint safeti chang reflux venou clinic sever score vcss
visual analogu scale va pain score patient complet
follow-up five experienc reduct reflux includ patient
consid occlud day averag reflux reduct day
compar day symptomat endpoint continu improv
well vcss score reduc averag vs day va
pain score reduc day vs day patient actual
experienc complet reduct reflux day though may temporari
measur tend fluctuat somewhat import take-away
patient within near normal level reflux correl
reduct signs/symptom diseas trial also includ patient
earlier follow-up day patient day patient
experienc substanti reduct across three metric select patient data
page
patient patient demonstr continu improv day
reduct reflux vs day patient va score improv
also largest go baselin
patient patient interest case patient implant consid
occlud day base reflux increas day appear
valv function patient improv baselin
percentag point improv addit patient vcss va score
remain consist baselin respect day
suggest occlus caus day result may
transient
patient despit day follow-up patient noteworthi case
sever reflux vcss va score maximum
scale baselin patient experienc reduct reflux near
normal level correl reduct vcss reduct
pain consid baselin sever patient could import case
studi clinic util
click full note
maxim analyst coverag univers
sector coverag
care well
industri util
